Senseonics Holdings (SENS)

• Market cap: $366M
• 1 day: -0.64%
• 5 days: -0.44%
• 1 month: -4.37%
• 3 months: -12.37%
• 6 months: -27.44%
• Year to date: -5.09%
• 1 year: 13.79%
• 5 years: 12.05%
• 10 years: -84.25%
• Sector: Technology
• Industry: Scientific & Technical Instruments

About: Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Employees: 117

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

62% more call options, than puts

Call options by funds: $471K | Put options by funds: $290K

38% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 26

27% more capital invested

Capital invested by funds: $56.9M [Q1] → $72.2M (+$15.3M) [Q2]

9.87% more ownership

Funds ownership: 13.3% [Q1] → 23.17% (+9.87%) [Q2]

0% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 22

1% less funds holding

Funds holding: 140 [Q1] → 139 (-1) [Q2]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $1.25
• Avg. target: $1.38
• High target: $1.5

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Barclays Matt Miksic	$1.5	Overweight Initiated	27 Aug 2025
TD Cowen Joshua Jennings	$1.25	Buy Initiated	15 Jul 2025
HC Wainwright & Co. Sean Lee	$1.4	Buy Maintained	8 Jul 2025